Analysts at Jefferies Financial Group initiated coverage on shares of Allurion Technologies (NYSE:ALUR – Get Free Report) in a report issued on Friday, Briefing.com reports. The firm set a “buy” rating and a $5.00 price target on the stock. Jefferies Financial Group’s price objective points to a potential upside of 68.92% from the stock’s previous close.
Allurion Technologies Trading Down 1.0 %
Shares of ALUR opened at $2.96 on Friday. Allurion Technologies has a 52-week low of $2.63 and a 52-week high of $9.00. The firm has a 50 day simple moving average of $3.35.
Allurion Technologies (NYSE:ALUR – Get Free Report) last issued its quarterly earnings results on Monday, November 13th. The company reported ($0.61) earnings per share (EPS) for the quarter. The business had revenue of $18.20 million during the quarter.
Institutional Investors Weigh In On Allurion Technologies
About Allurion Technologies
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
- Five stocks we like better than Allurion Technologies
- Energy and Oil Stocks Explained
- These cyber security stocks can hit new highs
- Want to Profit on the Downtrend? Downtrends, Explained.
- Arm Holdings: Earnings strength as clouds gather on the horizon
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- New York Community Bank stock plummets amid real estate risks
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.